Logo image of CUPR

CUPRINA HOLDINGS CAYMAN-A (CUPR) Stock Fundamental Analysis

NASDAQ:CUPR - Nasdaq - KYG2592E1026 - Common Stock - Currency: USD

4.54  -0.01 (-0.22%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CUPR. CUPR was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CUPR have multiple concerns. CUPR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CUPR Yearly Net Income VS EBIT VS OCF VS FCFCUPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -500K -1M -1.5M

1.2 Ratios

CUPR has a Return On Assets of -65.99%. This is in the lower half of the industry: CUPR underperforms 73.55% of its industry peers.
Industry RankSector Rank
ROA -65.99%
ROE N/A
ROIC N/A
ROA(3y)-67.12%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CUPR Yearly ROA, ROE, ROICCUPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 50 -50

1.3 Margins

CUPR has a worse Gross Margin (36.31%) than 69.84% of its industry peers.
CUPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CUPR Yearly Profit, Operating, Gross MarginsCUPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -500 -1K -1.5K -2K

More info and screens

2

2. Health

2.1 Basic Checks

CUPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CUPR has about the same amout of shares outstanding than it did 1 year ago.
CUPR has a better debt/assets ratio than last year.
CUPR Yearly Shares OutstandingCUPR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
CUPR Yearly Total Debt VS Total AssetsCUPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 500K 1M 1.5M

2.2 Solvency

An Altman-Z score of 6.27 indicates that CUPR is not in any danger for bankruptcy at the moment.
CUPR has a Altman-Z score of 6.27. This is amongst the best in the industry. CUPR outperforms 84.13% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 6.27
ROIC/WACCN/A
WACC9.22%
CUPR Yearly LT Debt VS Equity VS FCFCUPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 -500K -1M -1.5M -2M -2.5M

2.3 Liquidity

CUPR has a Current Ratio of 0.30. This is a bad value and indicates that CUPR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CUPR (0.30) is worse than 95.24% of its industry peers.
A Quick Ratio of 0.30 indicates that CUPR may have some problems paying its short term obligations.
CUPR has a worse Quick ratio (0.30) than 94.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.3
CUPR Yearly Current Assets VS Current LiabilitesCUPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

1

3. Growth

3.1 Past

CUPR shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.09%.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)78.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CUPR Yearly Revenue VS EstimatesCUPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 20K 40K 60K 80K 100K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CUPR Price Earnings VS Forward Price EarningsCUPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CUPR Per share dataCUPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CUPR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUPRINA HOLDINGS CAYMAN-A

NASDAQ:CUPR (5/22/2025, 8:00:00 PM)

4.54

-0.01 (-0.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap95.34M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1220.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS-0.13
TBVpS-0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.99%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.31%
FCFM N/A
ROA(3y)-67.12%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.3
Altman-Z 6.27
F-ScoreN/A
WACC9.22%
ROIC/WACCN/A
Cap/Depr(3y)86.42%
Cap/Depr(5y)N/A
Cap/Sales(3y)33.56%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)78.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.59%
OCF growth 3YN/A
OCF growth 5YN/A